Archives for February 18, 2009

← 2009

Celsis: time to put lab services on the block?

By Phil Taylor

UK company Celsis saw softness in demand across its operating divisions in the third quarter ended December 31, and said it was considering “strategic alternatives” for its laboratory services unit.

Green flip-flop solvents cut costs and damage

By Nick Taylor

Work into solvents that can switch polarity from an ionic to non-ionic form, negating the need to remove them after each step, has won a researcher the John C Polanyi Award.

MannKind’s loss mounts ahead of US Afresa submission

By Gareth Macdonald

MannKind, one of the inhaled-insulin market’s only remaining players, has posted higher than expected Q4 losses as costs for development of its lead product candidate Afresa increase ahead of its submission to the US FDA.

Bio-Imaging Tech dips into the red in Q4

By Phil Taylor

Contract research organisation Bio-Imaging Technologies posted a 48 per cent hike on revenues in the fourth quarter of 2008, but still made a small net loss on the back of its CapMed division, which was sold last month.

Valois to cut US timelines through expansion at Congers

By Gareth Macdonald

Valois Pharma is installing precision plastic molding capabilities at its manufacturing facility in Congers, New York, US as part of ongoing efforts to modernise its global manufacturing operations.

Asahi Kasei gains TechniKrom’s bioprocess business

By Gareth Macdonald

Japanese chemicals firm Asahi Kasei has ramped up its bioprocessing operations with the acquisition of US industrial processing specialist TechniKrom’s biopharmaceuticals business.